Open AccessThe real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: a multicenter study in South Korea
Author(s) -
Junhwan Kim,
Joseph J. Noh,
Tae Kyoung Lee,
Se Ik Kim,
JungYun Lee,
JeongWon Lee,
Jae Weon Kim
Publication year - 2021
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3802/jgo.2021.32.s1.om1
Subject(s) - lenvatinib , pembrolizumab , endometrial cancer , medicine , oncology , cancer , immunotherapy , thyroid cancer